A

Arecor Therapeutics PLC
LSE:AREC

Watchlist Manager
Arecor Therapeutics PLC
LSE:AREC
Watchlist
Price: 81.4 GBX 1.75% Market Closed
Market Cap: 30.7m GBX

Arecor Therapeutics PLC
Other Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Arecor Therapeutics PLC
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
A
Arecor Therapeutics PLC
LSE:AREC
Other Current Assets
ÂŁ971k
CAGR 3-Years
16%
CAGR 5-Years
99%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Other Current Assets
$8.9m
CAGR 3-Years
-19%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Other Current Assets
$23.2m
CAGR 3-Years
40%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Other Current Assets
ÂŁ20.9m
CAGR 3-Years
39%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Other Current Assets
ÂŁ6.5m
CAGR 3-Years
-43%
CAGR 5-Years
-31%
CAGR 10-Years
-19%
Oxford BioMedica PLC
LSE:OXB
Other Current Assets
ÂŁ5.2m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
21%
No Stocks Found

Arecor Therapeutics PLC
Glance View

Market Cap
30.7m GBX
Industry
Biotechnology

Arecor Therapeutics Plc is a biopharmaceutical company that targets improving patient care by bringing medicines to market through the enhancement of existing therapeutic products. The firm targets improving patient care by bringing medicines to market through the existing therapeutic products. The company partners with global pharmaceutical and biotechnology companies to apply the Arestat technology to their products under a technology licensing model. These products can be at any stage in development from early phase clinical development through to products that are already on the market. The areas of applications of the technology are biologicals, biosimilars, therapeutic vaccines and therapeutic peptides.

AREC Intrinsic Value
20.08 GBX
Overvaluation 75%
Intrinsic Value
Price
A

See Also

What is Arecor Therapeutics PLC's Other Current Assets?
Other Current Assets
971k GBP

Based on the financial report for Dec 31, 2024, Arecor Therapeutics PLC's Other Current Assets amounts to 971k GBP.

What is Arecor Therapeutics PLC's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
99%

Over the last year, the Other Current Assets growth was 201%. The average annual Other Current Assets growth rates for Arecor Therapeutics PLC have been 16% over the past three years , 99% over the past five years .

Back to Top